Editorial: The role of posttranslational modifications in polyglutamine diseases.
作者信息
Weber Jonasz Jeremiasz, Costa Maria do Carmo, Scaglione K Matthew, Todi Sokol V, Nguyen Huu Phuc
机构信息
Department of Human Genetics, Ruhr University Bochum, Bochum, Germany.
Institute of Medical Genetics and Applied Genomics, University of Tübingen, Tübingen, Germany.
出版信息
Front Mol Neurosci. 2023 Aug 15;16:1271226. doi: 10.3389/fnmol.2023.1271226. eCollection 2023.
Abstract
摘要
相似文献
1
Editorial: The role of posttranslational modifications in polyglutamine diseases.社论：翻译后修饰在多聚谷氨酰胺疾病中的作用
Front Mol Neurosci. 2023 Aug 15;16:1271226. doi: 10.3389/fnmol.2023.1271226. eCollection 2023.
2
Autophagy and Polyglutamine Disease.自噬与多聚谷氨酰胺病。
Adv Exp Med Biol. 2020;1207:149-161. doi: 10.1007/978-981-15-4272-5_9.
3
[Molecular biology of polyglutamine diseases].[多聚谷氨酰胺疾病的分子生物学]
Postepy Hig Med Dosw. 2002;56(6):779-88.
4
Trinucleotide repeats in neurologic diseases: an hypothesis concerning the pathogenesis of Huntington's disease, Kennedy's disease, and spinocerebellar ataxia type I.
Life Sci. 1994;54(20):1459-64. doi: 10.1016/0024-3205(94)90012-4.
5
Potential therapeutic targets in polyglutamine-mediated diseases.聚谷氨酰胺介导疾病中的潜在治疗靶点。
Expert Rev Neurother. 2014 Oct;14(10):1215-28. doi: 10.1586/14737175.2014.956727. Epub 2014 Sep 4.
6
Cerebellar allografts survive and transiently alleviate ataxia in a transgenic model of spinocerebellar ataxia type-1.在1型脊髓小脑共济失调的转基因模型中，小脑异体移植能够存活并短暂缓解共济失调症状。
Exp Neurol. 1999 Aug;158(2):301-11. doi: 10.1006/exnr.1999.7099.
7
[The advances in research on phosphorylation of polyglutamine disease].[聚谷氨酰胺疾病磷酸化研究进展]
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2008 Aug;25(4):414-7.
8
Beyond the glutamine expansion: influence of posttranslational modifications of ataxin-1 in the pathogenesis of spinocerebellar ataxia type 1.除了谷氨酰胺扩增：ataxin-1的翻译后修饰在1型脊髓小脑共济失调发病机制中的影响
Mol Neurobiol. 2014 Dec;50(3):866-874. doi: 10.1007/s12035-014-8703-z. Epub 2014 Apr 22.
9
Polyglutamine aggregation in Huntington's disease and spinocerebellar ataxia type 3: similar mechanisms in aggregate formation.亨廷顿病和脊髓小脑性共济失调 3 型中的多聚谷氨酰胺聚集：聚集形成中的相似机制。
Neuropathol Appl Neurobiol. 2016 Feb;42(2):153-66. doi: 10.1111/nan.12253. Epub 2015 Jul 2.
10
The Missing Link in Polyglutamine Diseases.聚谷氨酰胺疾病中的缺失环节
Mov Disord Clin Pract. 2017 Nov 20;5(1):29-30. doi: 10.1002/mdc3.12558. eCollection 2018 Jan-Feb.
本文引用的文献
1
Polyglutamine diseases.多聚谷氨酰胺疾病。
Curr Opin Neurobiol. 2022 Feb;72:39-47. doi: 10.1016/j.conb.2021.07.001. Epub 2021 Sep 3.
2
Posttranslational modifications in proteins: resources, tools and prediction methods.蛋白质的翻译后修饰：资源、工具和预测方法。
Database (Oxford). 2021 Apr 7;2021. doi: 10.1093/database/baab012.
3
Disease mechanism, biomarker and therapeutics for spinal and bulbar muscular atrophy (SBMA).脊髓和延髓肌肉萎缩症（SBMA）的发病机制、生物标志物和治疗方法。
J Neurol Neurosurg Psychiatry. 2020 Oct;91(10):1085-1091. doi: 10.1136/jnnp-2020-322949.
4
Site-specific ubiquitination of pathogenic huntingtin attenuates its deleterious effects.靶向泛素化致病性亨廷顿蛋白可减轻其有害影响。
Proc Natl Acad Sci U S A. 2020 Aug 4;117(31):18661-18669. doi: 10.1073/pnas.2007667117. Epub 2020 Jul 16.
5
Polyglutamine Repeats in Neurodegenerative Diseases.多聚谷氨酰胺重复在神经退行性疾病中的作用。
Annu Rev Pathol. 2019 Jan 24;14:1-27. doi: 10.1146/annurev-pathmechdis-012418-012857. Epub 2018 Aug 8.
6
The CAG-polyglutamine repeat diseases: a clinical, molecular, genetic, and pathophysiologic nosology.CAG多聚谷氨酰胺重复序列疾病：一种临床、分子、遗传和病理生理学分类学
Handb Clin Neurol. 2018;147:143-170. doi: 10.1016/B978-0-444-63233-3.00011-7.
7
Post-translational Modifications and Protein Quality Control in Motor Neuron and Polyglutamine Diseases.运动神经元与多聚谷氨酰胺疾病中的翻译后修饰和蛋白质质量控制
Front Mol Neurosci. 2017 Mar 31;10:82. doi: 10.3389/fnmol.2017.00082. eCollection 2017.
8
Proteolytic Cleavage of Polyglutamine Disease-Causing Proteins: Revisiting the Toxic Fragment Hypothesis.多聚谷氨酰胺病致病蛋白的蛋白水解切割：重新审视毒性片段假说。
Curr Pharm Des. 2017;23(5):753-775. doi: 10.2174/1381612822666161227121912.
9
The Biology of Huntingtin.亨廷顿蛋白的生物学。
Neuron. 2016 Mar 2;89(5):910-26. doi: 10.1016/j.neuron.2016.02.003.
10
From pathways to targets: understanding the mechanisms behind polyglutamine disease.从信号通路到靶点：理解多聚谷氨酰胺疾病背后的机制。
Biomed Res Int. 2014;2014:701758. doi: 10.1155/2014/701758. Epub 2014 Sep 21.
Zotero 插件